M&As this week: Sanofi, GE Healthcare, Medicure
Sanofi has announced plans to acquire US-based vaccines biotechnology company, Protein Sciences Corporation.
The French healthcare company will pay up to $750m for the acquisition, which will add recombinant-based influenza vaccine to its portfolio.
GE Healthcare has announced the acquisition of healthcare consulting firm Novia Strategies.
Novia Strategies will be incorporated into GE Healthcare Camden Group, complementing the division in areas such as care management transformation and non-labour cost reduction.
The acquisition will also enable GE Healthcare to expand its healthcare consulting business in the US.
Both companies involved in the acquisition are based in the US.
Canadian pharmaceutical company Medicure plans to acquire an additional stake in Apicore Inc. and Apicore LLC (together 'Apicore') for $24.5m.
The acquisition is being made through Medicure’s wholly owned Mauritius subsidiary and will increase the company’s ownership in Apicore Inc. to 98%.